The Synaptic Leap

There may be members of this community who do not yet have direct experience of developing a new medicine from concept to pharmacy shelf.  Be assured, there is a lot more to it than "just" the synthesis of the API.  Why not take advantage of a Free ACS Webcast on May 6, 2010 Thurs 2:00-3:00 PM ET
From a Beaker to a Bottle: Overview of the Drug Discovery and Development Process for Small Molecule Therapeutics
A free webcast from the American Chemical Society as part of their Professional Growth and Development Series. Learn about the drug development process and find out how long it takes, how much it costs, and the odds of getting a new drug approved.

Hi all,

I would like to introduce my open-source project at Stanford, GemIdent:

http://www.gemident.com

http://en.wikipedia.org/wiki/GemIdent

GemIdent specializes in color image segmentation using supervised machine learning. For example, you can use it to locate and count cells in microscopic images:

GemIdent in action identifying cancer cells in a IHC-stained lymphnode image

There's a new database from WHO for tracking new targets for drug discovery for neglected diseases. Not much there yet, but it's sure to grow.

Mat

Dear TSL Members,

You are invited to the first annual QB3-UCSF-CDD developing world disease research community meeting scheduled for March 5^th 2007 at the UCSF Mission Bay Campus (details below and attached).  The collaborative community includes leading experts on developing world infectious disease research from Stanford, UCSF, UC Berkeley, UCLA, UW, SBRI, St. Jude CRH, U. Penn, Univ. of Sydney, and industry too.  

Collaborative Drug Discovery
First Annual Community Meeting

Monday, March 5^th 2007 1:00-6:00 pm; Auditorium: J. David Gladstone Institute (1^st Floor)

Hosted by Gladstone Institute and QB3 at the UCSF, Mission Bay Campus

Two major themes of this event are:

1)      Public-Private-Partnerships for Global Health Issues
2)      “Open” concepts for Collaborative Drug Discovery

Confirmed Speakers:
 

• Dr. Christopher Lipinski, Pfizer, retired. (Keynote presentation)
  
• Jim McKerrow, Professor, Dept. of Pathology, QB3 - UCSF
  
• Matt Bogyo, Professor, Dept. of Pathology, Stanford Medical School
  
• Andrej Sali, Professor, Dept of Biopharmaceutical Sciences, QB3 - UCSF
  
• Dr. Anang Shelat, St. Jude Children’s Research Hospital
  
• David Roos, Biology Professor, Univ. of Penn tentatively confirmed (Director, Penn Genomics Institute).

Symposium – Coffee/Snacks – Demos – Posters – Networking – Wine Reception

Registration is free. To register contact/RSVP to: kgregory@collaborativedrug.com.